Literature DB >> 9869243

Target position variability throughout prostate radiotherapy.

L A Dawson1, K Mah, E Franssen, G Morton.   

Abstract

PURPOSE: To quantify the variability in prostate and seminal vesicle position during a course of external beam radiotherapy, and to measure the proportion of target variability due to setup error. METHODS AND MATERIALS: Forty-four weekly planning computerized tomography (CT) studies were obtained on six patients undergoing radiotherapy for prostate cancer. All patients were scanned in the radiotherapy treatment position, supine with an empty bladder, with no immobilization device. All organs were outlined on 3-mm-thick axial CT images. Anterior and lateral beam's eye view digitally reconstructed radiographs and multiplanar reformatted images were generated. The position of the prostate and seminal vesicles relative to the isocenter location as set that day was recorded for each CT study. Target position relative to a bony landmark was measured to determine the relative contribution of setup error to the target position variability.
RESULTS: The seminal vesicle and prostate position variability was most significant in the anterior-posterior (AP) direction, followed by cranial-caudal (CC) and mediolateral (ML) directions. Setup error contributed significantly to the total target position variability. Rectal filling was associated with a trend to anterior movement of the prostate, whereas bladder filling was not associated with any trends. Although most deviations from the target position determined at the initial planning CT scan were within 10 mm, deviations as large as 15 mm and 19 mm were seen in the prostate and seminal vesicles respectively. Target position variations were evenly distributed around the initial target position for some patient studies, but unpredictable patterns were also seen. From a simulation based on the observed variability in target position, the AP, CC, and ML planning target volume (PTV) borders around the clinical target volume (CTV) required for target coverage with 95% certainty are 12.4 mm, 10.3 mm, and 5.6 mm respectively for the prostate and 13.8 mm, 8.6 mm, and 3.9 mm respectively for the seminal vesicles.
CONCLUSION: Target position variability is significant during prostate radiotherapy, requiring large PTV borders around the CTV. This target position variability may be potentially reduced by improving the setup accuracy.

Entities:  

Mesh:

Year:  1998        PMID: 9869243     DOI: 10.1016/s0360-3016(98)00265-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Uncertainties and CTV to PTV margins quantitative assessment using cone-beam CT technique in clinical application for prostate, and head and neck irradiation tumours.

Authors:  X J Juan-Senabre; J López-Tarjuelo; A Conde-Moreno; A Santos-Serra; A L Sánchez-Iglesias; J D Quirós-Higueras; N de Marco Blancas; S Calzada-Feliu; C Ferrer-Albiach
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

2.  Which bowel preparation is best? Comparison of a high-fibre diet leaflet, daily microenema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on planned target volume shifts due to rectal distension.

Authors:  S Yahya; A Zarkar; E Southgate; P Nightingale; G Webster
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

3.  CTV to PTV margins for prostate irradiation. Three-dimensional quantitative assessment of interfraction uncertainties using portal imaging and serial CT scans.

Authors:  Luis A Pérez-Romasanta; Eva Lozano-Martín; Joaquín Velasco-Jiménez; Fermín Mendicote-León; Miguel Sanz-Martín; Javier Torres-Donaire; Carmen Carrascosa-Fernández; Juan Carlos Zapata-Jimínez; Jacinto Arjona-Gutiérrez; Antonio Gil-Agudo
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

4.  Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: analysis of a randomized clinical trial.

Authors:  Annemarie M den Harder; Carla H van Gils; Alexis N T J Kotte; Marco van Vulpen; Irene M Lips
Journal:  Strahlenther Onkol       Date:  2014-04-24       Impact factor: 3.621

5.  Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Dario Zerini; Federica Cattani; Flavia Serafini; Rosa Luraschi; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

6.  Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment.

Authors:  Ning Wen; Carri Glide-Hurst; Teamour Nurushev; Lei Xing; Jinkoo Kim; Hualiang Zhong; Dezhi Liu; Manju Liu; Jay Burmeister; Benjamin Movsas; Indrin J Chetty
Journal:  Phys Med Biol       Date:  2012-08-03       Impact factor: 3.609

7.  Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy.

Authors:  Siyuan Lei; Nathaniel Piel; Eric K Oermann; Viola Chen; Andrew W Ju; Kedar N Dahal; Heather N Hanscom; Joy S Kim; Xia Yu; Guowei Zhang; Brian T Collins; Reena Jha; Anatoly Dritschilo; Simeng Suy; Sean P Collins
Journal:  Front Oncol       Date:  2011-12-08       Impact factor: 6.244

8.  Improvements in radiotherapy practice: the impact of new imaging technologies.

Authors:  David Driver; H Jane Dobbs
Journal:  Cancer Imaging       Date:  2004-10-21       Impact factor: 3.909

9.  Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Authors:  S Stanley; S Griffiths; M R Sydes; A R Moore; I Syndikus; D P Dearnaley
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-06-18       Impact factor: 4.126

10.  Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.

Authors:  Sumit Sood; Andrew W Ju; Honkung Wang; Siyuan Lei; Sunghae Uhm; Guowei Zhang; Simeng Suy; John Carroll; John Lynch; Anatoly Dritschilo; Sean P Collins
Journal:  Radiat Oncol       Date:  2013-08-09       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.